Bionic Vision Technologies logo — Restoring a sense of vision to the blind.

Bionic Vision Technologies

Restoring a sense of vision to the blind.

Founded 2010 Australia Australia 6 employees Series A Total: $18.00M Biotechnology, Health Care +1

General Information

Company Name Bionic Vision Technologies
Founded Year 2010
Location Australia Australia +2
Founders / Decision Makers
Team member Team member
Employees 6
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series A
Social

Get notified when Bionic Vision Technologies moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Bionic Vision Technologies

Bionic Vision Technologies (BVT) is an Australian startup pioneering in the development of visual prostheses to restore vision to the blind. The company, founded in 2010, focuses on leveraging biotechnology and healthcare expertise to create innovative solutions for individuals suffering from retinal degeneration. BVT's devices utilize electrical stimulation to activate the remaining retinal cells in patients, aiming to provide them with a renewed sense of sight. In April 2017, the company secured a noteworthy $18.00M Series A investment, with prominent backers including China Huarong International Holdings Limited and State Path Capital Limited. BVT's steadfast pursuit of pioneering medical technology showcases great potential for addressing unmet needs in the healthcare industry and improving the quality of life for individuals affected by visual impairments.

Taxonomy: Bionic Vision Technologies, visual prostheses, blindness, retinal degeneration, innovation, visual impairment, bionic technology, sensory restoration

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 2
Investor
•••• ••••
03 Apr 2017
Grant •••••• 1
Investor
01 Oct 2014

Bionic Vision Technologies Alternatives & Competitors

Bionic Vision Technologies vs

Optogenetic Gene Therapy Company

Series B
46 employees
Biotechnology, Health Care
Bionic Vision Technologies vs

Innovating at the frontier of neuroscience : brain machine interfacing the Eye and the Brain - from...

Post Ipo Equity
13 employees
Health Care, Information Technology
Bionic Vision Technologies vs

EyeCheckup is an early diagnosis system for preventing vision loss using artificial intelligence.

Seed
4 employees
AI, Health Care
Also compare with: Bionic Vision Technologies vs SPRING Vision SPRING Vision

FAQ About Bionic Vision Technologies

Restoring a sense of vision to the blind.
Bionic Vision Technologies was founded in 2010.
Bionic Vision Technologies is headquartered in Australia.
Bionic Vision Technologies operates in the following industries: Biotechnology, Health Care, Medical Devices.
Bionic Vision Technologies has approximately 6 employees.
Bionic Vision Technologies has completed 2 funding rounds, raising a total of $18.00M. The latest funding stage is Series A.
Top alternatives and competitors to Bionic Vision Technologies include Ray Therapeutics, Inc., Pixium Vision S.A., EyeCheckup - early diagnosis, Notal Vision, SPRING Vision . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bionic Vision Technologies and Ray Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Bionic Vision Technologies and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes